文献速递关节外科

糖皮质激素用于全膝关节置换术关节周围浸润镇痛的疗效与安全性:随机对照试验的系统综述与Meta分析

The Efficacy and Safety of Glucocorticoid on Periarticular Infiltration Analgesia in Total Knee Arthroplasty: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
PubMed 文献 · J Arthroplasty · 2021-04-26

该系统综述与Meta分析纳入11项随机对照试验共1051例初次全膝关节置换术,评估含或不含糖皮质激素的多模式鸡尾酒方案在关节周围浸润镇痛中的效果与安全性。结果显示糖皮质激素组术后第1、2天VAS评分显著更低,术后第1天活动度改善,24小时吗啡消耗量减少,术后第2/3天C反应蛋白水平更低;住院时间和长期膝关节协会评分无差异,且不增加并发症或副作用。亚组分析提示曲安奈德在术后VAS评分和活动度方面优于倍他米松、甲泼尼龙和地塞米松。

要点

  • 糖皮质激素加入关节周围浸润镇痛可显著降低全膝关节置换术后第1、2天疼痛评分。
  • 糖皮质激素组术后第1天活动度改善,24小时吗啡消耗量减少,术后第2/3天C反应蛋白更低。
  • 不增加并发症或副作用,住院时间和长期膝关节协会评分无差异;曲安奈德可能更优。

核心结论

  • 在关节周围浸润镇痛中加入糖皮质激素对单侧或双侧全膝关节置换患者有效,且不增加并发症或副作用。
  • 曲安奈德可作为多模式鸡尾酒方案中糖皮质激素补充的推荐选择。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Medline、Embase和Cochrane Library数据库截至2020年11月,纳入11项随机对照试验共1051例初次全膝关节置换术(930例患者)。

主要发现

  • 糖皮质激素组术后第1天VAS评分显著低于对照组(95%CI [-1.01--0.10],P = .02)。
  • 糖皮质激素组术后第2天VAS评分显著低于对照组(95%CI [-0.51--0.13],P = .001)。
  • 糖皮质激素组术后第1天活动度显著改善(95%CI [3.20-8.05],P < .00001)。
  • 糖皮质激素组24小时总吗啡消耗量减少,术后第2/3天C反应蛋白水平更低。
  • 两组住院时间和长期膝关节协会膝关节评分无差异。

关键数值与推荐

  • 亚组分析显示,在术后VAS评分和活动度方面,曲安奈德优于倍他米松、甲泼尼龙和地塞米松。

临床怎么用

  • 全膝关节置换术中可在关节周围浸润镇痛的多模式鸡尾酒方案中加入糖皮质激素以改善术后早期镇痛和活动度。
  • 若选择糖皮质激素,曲安奈德可能具有更优的镇痛和活动度获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The objective of this systematic review and meta-analysis was to examine the effect and safety of multimodal cocktail protocols implemented with or without glucocorticoids on periarticular infiltration analgesia (PIA) in patients undergoing total knee arthroplasty (TKA). METHODS: We comprehensively searched the PubMed, Medline, Embase, and Cochrane Library databases up to November 2020 for randomized controlled trials on glucocorticoids as a component of the cocktail protocol used in PIA for patients with TKA. RESULTS: Our meta-analysis included 11 randomized controlled trial studies with 1051 primary TKAs (930 patients). Visual analog scale scores at postoperative day (POD) 1 and POD 2 in the glucocorticoid groups were significantly lower than those in the control group (95% CI [-1.01--0.10], P = .02; 95% CI [-0.51--0.13], P = .001). Furthermore, the glucocorticoid group was associated with a statistically significant improvement in the range of motion at POD 1 (95% CI [3.20-8.05] P < .00001), reduction in total morphine consumption at 24 hours, and lower levels of C-reactive protein on POD 2/3 compared with the control group. However, neither the length of hospital stays nor the long-term Knee Society Knee Score showed any differences between the two groups. In addition, the results of subgroup analyses favored triamcinolone acetonide over betamethasone, methylprednisolone, and dexamethasone regarding the postoperative visual analog scale scores and range of motion. CONCLUSION: Glucocorticoid supplementation in PIA is effective and does not increase complications or side effects for patients with either unilateral or bilateral TKA. Moreover, triamcinolone acetonide could be recommended in multimodal cocktail protocols for glucocorticoid supplementation.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Li Z, Li Z, Cheng K, et al. The Efficacy and Safety of Glucocorticoid on Periarticular Infiltration Analgesia in Total Knee Arthroplasty: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Arthroplasty. 2021. PMID: 33926778. doi:10.1016/j.arth.2021.03.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。